Platelet Proteomic Analysis Revealed Differential Pattern of Cytoskeletal- and Immune-Related Proteins at Early Stages of Alzheimer’s Disease

[1]  Holger Gohlke,et al.  Platelets contribute to amyloid-β aggregation in cerebral vessels through integrin αIIbβ3–induced outside-in signaling and clusterin release , 2016, Science Signaling.

[2]  Tong Zhang,et al.  Increased apoptosis in the platelets of patients with Alzheimer’s disease and amnestic mild cognitive impairment , 2016, Clinical Neurology and Neurosurgery.

[3]  B. McGuinness,et al.  Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study , 2015, Journal of Alzheimer's disease : JAD.

[4]  I. Ferrer,et al.  Expression of Regulatory Proteins in Choroid Plexus Changes in Early Stages of Alzheimer Disease , 2015, Journal of neuropathology and experimental neurology.

[5]  R. Morishita,et al.  Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy , 2014, Front. Aging Neurosci..

[6]  D. Dash,et al.  Amyloid β peptide stimulates platelet activation through RhoA‐dependent modulation of actomyosin organization , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  N. S. Gowert,et al.  Blood Platelets in the Progression of Alzheimer’s Disease , 2014, PloS one.

[8]  O. Forlenza,et al.  Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study , 2014, Journal of Neural Transmission.

[9]  L. Provinciali,et al.  Amyloid precursor protein expression is enhanced in human platelets from subjects with Alzheimer's disease and frontotemporal lobar degeneration: A Real-time PCR study , 2013, Experimental Gerontology.

[10]  C. Humpel,et al.  Platelet-derived secreted amyloid-precursor protein-β as a marker for diagnosing Alzheimer's disease. , 2013, Current neurovascular research.

[11]  Nathan J. Harris,et al.  Talin Autoinhibition Is Required for Morphogenesis , 2013, Current Biology.

[12]  W. H. Goldmann,et al.  Vinculin, cell mechanics and tumour cell invasion , 2013, Cell biology international.

[13]  Michael S. McGrath,et al.  Systemic immune system alterations in early stages of Alzheimer's disease , 2013, Journal of Neuroimmunology.

[14]  G. Ricevuti,et al.  Alzheimer disease and platelets: how’s that relevant , 2012, Immunity & Ageing.

[15]  Nick C Fox,et al.  The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[16]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[17]  A. Nurden.  Platelets, inflammation and tissue regeneration , 2011, Thrombosis and Haemostasis.

[18]  M. Barbagallo,et al.  Systemic immune responses in Alzheimer's disease: in vitro mononuclear cell activation and cytokine production. , 2010, Journal of Alzheimer's disease : JAD.

[19]  P. Lewczuk,et al.  Differential processing and secretion of Aβ peptides and sAPPα in human platelets is regulated by thrombin and prostaglandine 2 , 2009, Neurobiology of Aging.

[20]  C. Adler,et al.  Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease , 2009, Alzheimer's & Dementia.

[21]  Lavanya Vasudevan,et al.  Focal adhesion proteins connect IgE receptors to the cytoskeleton as revealed by micropatterned ligand arrays , 2008, Proceedings of the National Academy of Sciences.

[22]  I. Morita,et al.  Altered Function of Factor I Caused by Amyloid β: Implication for Pathogenesis of Age-Related Macular Degeneration from Drusen1 , 2008, The Journal of Immunology.

[23]  D. Craig,et al.  Platelet β-secretase activity is increased in Alzheimer's disease , 2008, Neurobiology of Aging.

[24]  J. Emsley,et al.  Integrin connections to the cytoskeleton through talin and vinculin. , 2008, Biochemical Society transactions.

[25]  T. Casoli,et al.  Platelet as a physiological model to investigate apoptotic mechanisms in Alzheimer β-amyloid peptide production , 2008, Mechanisms of Ageing and Development.

[26]  D. Craig,et al.  Platelet beta-secretase activity is increased in Alzheimer's disease. , 2008, Neurobiology of aging.

[27]  L. Provinciali,et al.  Modifications of platelet from Alzheimer disease patients: A possible relation between membrane properties and NO metabolites , 2007, Neurobiology of Aging.

[28]  Á. Martín-Requero,et al.  Impaired apoptosis in lymphoblasts from Alzheimer’s disease patients: Cross-talk of Ca2+/calmodulin and ERK1/2 signaling pathways , 2007, Cellular and Molecular Life Sciences.

[29]  D. Bonifati,et al.  Role of complement in neurodegeneration and neuroinflammation. , 2007, Molecular immunology.

[30]  T. Casoli,et al.  Release of beta-amyloid from high-density platelets: implications for Alzheimer's disease pathology. , 2007, Annals of the New York Academy of Sciences.

[31]  Elina Ikonen,et al.  When intracellular logistics fails - genetic defects in membrane trafficking , 2006, Journal of Cell Science.

[32]  Rena Li,et al.  Peripheral clearance of amyloid β peptide by complement C3-dependent adherence to erythrocytes , 2006, Neurobiology of Aging.

[33]  E. Ross,et al.  Coated-platelets retain amyloid precursor protein on their surface , 2006, Platelets.

[34]  R. Rosenberg,et al.  Platelet amyloid precursor protein processing: A bio-marker for Alzheimer's disease , 2006, Journal of the Neurological Sciences.

[35]  T. Keränen,et al.  GABA and glutamate transporters are expressed in human platelets. , 2005, Brain research. Molecular brain research.

[36]  C. Scavone,et al.  Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease , 2005, Neurobiology of Aging.

[37]  E. Favale,et al.  Decrease of Serotonin Transporters in Blood Platelets after Epileptic Seizures , 2005, Neurochemical Research.

[38]  M. Carroll,et al.  The complement system in regulation of adaptive immunity , 2004, Nature Immunology.

[39]  C Caltagirone,et al.  Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease , 2004, Neurology.

[40]  P. Eikelenboom,et al.  Immunoglobulins and complement factors in senile plaques , 1982, Acta Neuropathologica.

[41]  Colin L Masters,et al.  Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets , 2003, Journal of neuroscience research.

[42]  P. Gasque,et al.  Activation of Complement in the Central Nervous System , 2003, Annals of the New York Academy of Sciences.

[43]  R. Strohmeyer,et al.  Association of factor H of the alternative pathway of complement with agrin and complement receptor 3 in the Alzheimer's disease brain , 2002, Journal of Neuroimmunology.

[44]  R. Rosenberg,et al.  Platelet APP isoform ratios correlate with declining cognition in AD , 2000, Neurology.

[45]  D. Cribbs,et al.  β amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium : Usage of a novel blood brain barrier endothelial cell model system , 2000, Neurobiology of Aging.

[46]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[47]  D. Cribbs,et al.  β amyloid fragments derived from activated platelets deposit in cerebrovascular endothelium: Usage of a novel blood brain barrier endothelial cell model system , 2000 .

[48]  C. Abraham,et al.  Platelets and DAMI megakaryocytes possess β-secretase-like activity , 1999 .

[49]  C. Abraham,et al.  Platelets and DAMI megakaryocytes possess beta-secretase-like activity. , 1999, The Journal of laboratory and clinical medicine.

[50]  A. Billingslea,et al.  Activated Alzheimer Disease Platelets Retain More Beta Amyloid Precursor Protein , 1997, Neurobiology of Aging.

[51]  L. Honig,et al.  Altered amyloid protein processing in platelets of patients with Alzheimer disease. , 1997, Archives of neurology.

[52]  N. Inestrosa,et al.  Platelets Are the Primary Source of Amyloid β-Peptide in Human Blood , 1995 .

[53]  N. Inestrosa,et al.  Platelets are the primary source of amyloid beta-peptide in human blood. , 1995, Biochemical and biophysical research communications.

[54]  P. Mcgeer,et al.  Brain microglia constitutively express β-2 integrins , 1990, Journal of Neuroimmunology.

[55]  R. Martins,et al.  The amyloid precursor protein of Alzheimer's disease is released by human platelets. , 1990, The Journal of biological chemistry.

[56]  P. Mcgeer,et al.  Brain microglia constitutively express beta-2 integrins. , 1990, Journal of neuroimmunology.

[57]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.